Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM. (2008)

First Author: Wickenden JA
Attributed to:  How does ERK1/2-dependent phosphorylation target BimEL to the proteasome? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2008.335

PubMed Identifier: 18806830

Publication URI: http://europepmc.org/abstract/MED/18806830

Type: Journal Article/Review

Volume: 27

Parent Publication: Oncogene

Issue: 57

ISSN: 0950-9232